Clinical Effect of Rebamipide on Chronic Gastritis
Clinical Effect of Rebamipide on Chronic Gastritis
To investigate the clinical effect of rebamipide in chronic gastritis patients. Patients with
 chronic gastritis were randomly divided into the experimental group and the control group.
 The experimental group were treated with rebamipide 0.1g tid and optimization of life style,
 and the control group were only optimized their life style for 26 weeks. Upper
 gastrointestinal endoscopy was performed in all patients to evaluate the severity of
 gastritis by modified Lanza score (MLS) and the histology by the updated Sydney system before
 and after treatment.
Inclusion Criteria:

 -  With the symptoms as follow: epigastric pain, abdominal discomfort, abdominal
 distention, poor appetite, nausea, vomiting and so on

 -  diagnosed as chronic gastritis with endoscopic and pathological methods

 -  agree to join in this clinical trail

 Exclusion Criteria:

 -